HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuyi Si Selected Research

norvancomycin

2/2021Comparative genomics and transcriptomics analyses provide insights into the high yield and regulatory mechanism of Norvancomycin biosynthesis in Amycolatopsis orientalis NCPC 2-48.
1/2017Three structurally-related impurities in norvancomycin drug substance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuyi Si Research Topics

Disease

16Atherosclerosis
01/2020 - 03/2007
8Neoplasms (Cancer)
01/2019 - 08/2007
5Tuberculosis (Tuberculoses)
01/2021 - 01/2014
4Infections
02/2021 - 09/2014
4Inflammation (Inflammations)
01/2020 - 01/2017
3Bacterial Infections (Bacterial Infection)
04/2019 - 01/2017
3Hepatocellular Carcinoma (Hepatoma)
05/2009 - 12/2004
2Osteoporosis
11/2021 - 08/2016
2Cardiovascular Diseases (Cardiovascular Disease)
02/2020 - 01/2018
2Atherosclerotic Plaque (Atheroma)
01/2020 - 01/2018
1Extensively Drug-Resistant Tuberculosis
11/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1COVID-19
12/2021
1Myeloperoxidase Deficiency
01/2021
1Chronic Disease (Chronic Diseases)
01/2020
1Mycoses (Diseases, Fungus)
08/2019
1Cachexia
01/2019
1Weight Loss (Weight Reduction)
01/2019
1Muscular Atrophy (Muscle Atrophy)
01/2019
1Hyperlipidemias (Hyperlipidemia)
01/2018
1Insulin Resistance
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Metabolic Diseases (Metabolic Disease)
01/2018
1Pulmonary Arterial Hypertension
01/2018
1Weight Gain
04/2015
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2014
1Decompression Sickness (Bends)
04/2013
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
03/2012

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
11/2022 - 08/2007
10CholesterolIBA
02/2020 - 08/2008
6Apolipoproteins E (ApoE)IBA
01/2020 - 08/2014
4LipidsIBA
01/2020 - 08/2008
3rutecarpineIBA
01/2020 - 08/2014
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 09/2014
3ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2018 - 08/2008
3Liver X ReceptorsIBA
05/2016 - 04/2014
3norharmanIBA
01/2012 - 08/2007
2Anti-Infective Agents (Microbicides)IBA
11/2022 - 09/2018
2Antiviral Agents (Antivirals)IBA
12/2021 - 07/2015
2OsteoprotegerinIBA
11/2021 - 08/2016
2norvancomycinIBA
02/2021 - 01/2017
2LigandsIBA
01/2021 - 08/2016
2Glucose (Dextrose)FDA LinkGeneric
02/2020 - 04/2015
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
2Sirtuin 1IBA
01/2018 - 01/2018
2LuciferasesIBA
01/2017 - 08/2008
2DNA (Deoxyribonucleic Acid)IBA
04/2014 - 04/2013
2Phospholipids (Phosphatides)FDA LinkGeneric
11/2011 - 08/2008
2Apolipoprotein A-I (Apolipoprotein A1)IBA
11/2011 - 08/2008
1Clofazimine (Lamprene)FDA Link
11/2022
1Cysteine (L-Cysteine)FDA Link
01/2022
1DeoxyuridineIBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1dUTP pyrophosphataseIBA
01/2021
1tempolIBA
01/2021
1oxidized low density lipoproteinIBA
01/2020
1AntioxidantsIBA
01/2020
1InflammasomesIBA
01/2020
1Antifungal AgentsIBA
08/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1GemcitabineFDA Link
01/2019
1UbiquitinIBA
01/2019
1IMB5043IBA
01/2018
1E1231IBA
01/2018
1Triglycerides (Triacylglycerol)IBA
01/2018
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2018
1MonocrotalineIBA
01/2018
1Arachidonic Acid (Vitamin F)IBA
01/2018
1piperidineIBA
01/2018
1Semaxinib (SU5416)IBA
01/2018
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2018
1Small Interfering RNA (siRNA)IBA
11/2017
1Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
11/2017
1VorinostatFDA Link
11/2017
1Polo-Like Kinase 1IBA
01/2017
1Tannic AcidFDA Link
01/2017
1sansanmycinIBA
05/2016
1morpholinoanthracycline MX2 (MX-2)IBA
05/2016
1resazurinIBA
08/2015
12- (2- (1,2- dimethyl- 1H- indol- 3- yl)- 2- oxoacetylamino)benzamideIBA
04/2015
1Insulin (Novolin)FDA Link
04/2015
1p38 Mitogen-Activated Protein KinasesIBA
04/2014
1Serine (L-Serine)FDA Link
04/2014
1ThiazolesIBA
04/2014
1Histones (Histone)IBA
04/2014
1Capreomycin (Capastat)FDA Link
01/2014
1SOX Transcription FactorsIBA
04/2013
1IMB2026791IBA
03/2012
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2010
1Cyclin B1IBA
12/2009
1theasinensin AIBA
05/2009
1trichostatin A (A 300)IBA
05/2009
1OxysterolsIBA
08/2008
1HDL LipoproteinsIBA
08/2008
1ThiazolidinedionesIBA
08/2008

Therapy/Procedure

4Therapeutics
02/2020 - 08/2008
1Aftercare (After-Treatment)
01/2012
1Drug Therapy (Chemotherapy)
12/2010